2020-07-06 Authoring Clinical Steering Committee Meeting Agenda and Notes

Attendees

Agenda Item
Review project outline SM-What has worked well? JS- Too early to tell MM-Confluence has worked fine so far KR-Group is still gaining momentum

Meeting Notes

Business Use Case Analysis

Statement of Value

What is the benefits
What are the key value statements for different action and communications
Target Audience: Arriving toward and organization that wants to do authoring of clinical pathways
Differentiate between those that want to do authoring verse those that are trying to consume authored artifacts

Out of Scope of Authoring Work group

Why an institution would want to adopt or institute shareable pathways
Bill: Are there studies about how pathways are instituted and used, and the implications of that. (ref: Look at oncology Pathways)

Examples:

Work What Success looks like? (6-12 mos)

Why would someone want to be involved
What is the path-How do I start, and what does the path look like?
Best practices-how do I do this well ? What has been learned?
- What guidance should I follow?
Why should I want to be an author involved in BPM+?
How does one take a 100+page PDF guideline and make it into a machine readable model that could be ingested into a system.” Taking the story, approach, tips, tricks, etc. so that other can do this. Either de novo or adapting existing content. This is authoring.
- New clinical societies
- Healthcare delivery orgs
Why would an organization choose this ?
If we make the decision, how do we make it so?
What does “doing it well” looks like: (e.g. Maturity Model, etc.)

Work Products to do this

Artifact:

Purpose:

Audience:

Thank you all!

Next Mtgs:

Authoring Clinical Steering Committee on Thursday, July 9, 12:00PM – 1:00pm EST
Workgroup on Monday, June, 20 2:30pm – 4pm EST